Health ❯Pharmaceuticals ❯Drug Approval

FDA

Clinical Trials Donanemab Kisunla Public Health Nonaddictive Pain Medication

Global Stocks Rally on Robust US Data as Fed Rate Cut Odds Diminish

Strong US jobless claims are driving record Wall Street highs under the shadow of an August 1 tariff deadline

Stories older than 24h

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland